Correlation Between Emergent Biosolutions and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Emergent Biosolutions and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Tarsus Pharmaceuticals.
Diversification Opportunities for Emergent Biosolutions and Tarsus Pharmaceuticals
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Emergent and Tarsus is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Emergent Biosolutions and Tarsus Pharmaceuticals
Considering the 90-day investment horizon Emergent Biosolutions is expected to generate 1.33 times less return on investment than Tarsus Pharmaceuticals. In addition to that, Emergent Biosolutions is 2.05 times more volatile than Tarsus Pharmaceuticals. It trades about 0.03 of its total potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about 0.08 per unit of volatility. If you would invest 1,374 in Tarsus Pharmaceuticals on December 4, 2024 and sell it today you would earn a total of 2,898 from holding Tarsus Pharmaceuticals or generate 210.92% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Emergent Biosolutions vs. Tarsus Pharmaceuticals
Performance |
Timeline |
Emergent Biosolutions |
Tarsus Pharmaceuticals |
Emergent Biosolutions and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Emergent Biosolutions and Tarsus Pharmaceuticals
The main advantage of trading using opposite Emergent Biosolutions and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |